¼¼°èÀÇ Ã¢»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ½ÃÀå
Wound Debridement Products
»óǰÄÚµå : 1514136
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 272 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,372,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,117,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Ã¢»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ½ÃÀåÀº 2030³â±îÁö 17¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 11¾ï ´Þ·¯·Î Æò°¡µÈ ¼¼°èÀÇ Ã¢»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ½ÃÀåÀº 2030³â¿¡´Â 17¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 6.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ È¿¼Ò â»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç°Àº CAGR 7.4%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 7¾ï 7,410¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ö¼ú â»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 9,690¸¸ ´Þ·¯, Áß±¹Àº CAGR 9.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ã¢»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ½ÃÀåÀº 2023³â 2¾ï 9,690¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGR 9.8%·Î Àü¸ÁµÇ¸ç, 2030³â±îÁö 4¾ï 1,270¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.2%¿Í 5.7%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ã¢»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ½ÃÀå-ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

â»ó Á¦°Å´Â ¿åâ, Á¤¸Æ¼º ±Ë¾ç, ´ç´¢º´¼º ¹ß±Ë¾ç°ú °°Àº ¸¸¼º »óó¸¦ °ü¸®ÇÏ´Â µ¥ Áß¿äÇÑ Á¶Ä¡À̸ç Ä¡À¯ °úÁ¤À» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ÀÇ·á ÀýÂ÷´Â ±«»çµÇ°Å³ª Á×Àº Á¶Á÷À» Á¦°ÅÇÕ´Ï´Ù. ±«»çµÈ Á¶Á÷Àº ¹ÚÅ׸®¾Æ¸¦ º¸À¯ÇÏ°í »õ·Î¿î Á¶Á÷ÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÏ¿© Ä¡À¯¸¦ ¹æÇØÇÕ´Ï´Ù. ÆÄ»ýÀÇ ¹æ¹ýÀº »óóÀÇ À¯Çü°ú »óÅ¿¡ µû¶ó ´Ù¾çÇÏ¸ç »óó °ü¸®ÀÇ Áß¿äÇÑ Ãø¸éÀÔ´Ï´Ù. ÀÚ°¡ ¼ÒÈ­¼º DebreadmanÀº ½ÅüÀÇ ¸ÞÄ¿´ÏÁòÀ» ÀÌ¿ëÇÏ¿© »ýÁ¸ ºÒ°¡´ÉÇÑ Á¶Á÷À» ºÎµå·´°Ô Á¦°ÅÇÏ¸ç °¨¿°µÇÁö ¾ÊÀº »óó¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. »ý¹°ÇÐÀû µ¥ºí¸®µå¸Ç(À¯»ý¿ä¹ý)°ú È¿¼ÒÀû µ¥ºê¸®µå¸ÇÀº »ç¸ÁÇÑ Á¶Á÷À» ½î°í Á¦°ÅÇÏ¿© Å« »óó³ª °¨¿°µÈ »óó¿¡ ÀûÇÕÇÕ´Ï´Ù. ±â°èÀû ÆÄ±«ÀÚ¿Í ³¯Ä«·Î¿î ÆÄ±«ÀÚ´Â º¸´Ù ½Å¼ÓÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇϸç, ÈÄÀÚ´Â Áï°¢ÀûÀÎ °³¼±À» Á¦°øÇϸç, ƯÈ÷ ±âÃÊ ÁúȯÀÇ ½Å¼ÓÇÑ Æò°¡¿Í Ä¡·á¿¡ À¯¿ëÇÕ´Ï´Ù.

â»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç° ½ÃÀåÀº ¿©·¯ ¼ºÀå ÃËÁø¿äÀο¡ ÀÇÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼º »óó°¡ Áõ°¡ÇÔ¿¡ µû¶ó ºó¹øÇÑ ±«»çÁ¶Á÷ Á¦°Å°¡ ÇÊ¿äÇϸç È¿À²ÀûÀÎ ±«»çÁ¶Á÷ Á¦°Å Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »óó Ä¡·á ±â¼úÀÇ ¹ßÀüÀº Ä¡·á È¿°ú¸¦ Çâ»ó½ÃŰ°í °í±Þ Á¦Ç°À» ´õ¿í ¸Å·ÂÀûÀ¸·Î ¸¸µì´Ï´Ù. ¶ÇÇÑ »óó °ü¸®°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀ» ¾Î°íÀÖ´Â ¼¼°è Àα¸ÀÇ ³ëÈ­´Â ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©ÇÕ´Ï´Ù. ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚ°£¿¡ ÀûÀýÇÑ »óó ÄɾîÀÇ ÀÌÁ¡¿¡ ´ëÇÑ Àνİú ±³À°ÀÌ ³ô¾ÆÁö°í, ÀÇ·áºñÀÇ °³¼±¿¡ ÀÇÇØ ¾çÁúÀÇ »óó ÄɾÀÇ ¾×¼¼½º°¡ Çâ»óµÇ°í ÀÖ´Â °Íµµ, ¸Å¿ì Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

â»ó ±«»çÁ¶Á÷ Á¦°Å Á¦Ç°ÀÇ °³¹ß ¹× »ç¿ëÀº ±ÔÁ¦ ¹× »óȯ »óȲ¿¡µµ ¿µÇâÀ» ¹Þ½À´Ï´Ù. Çõ½ÅÀûÀÎ ½ÅÁ¦Ç°¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀÌ º¸´Ù ºü¸£°í ÀÚÁÖ ÀÌ·ç¾îÁö´Â °ÍÀº ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚÀÇ µ¿±âºÎ¿©°¡ µË´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ¼±Áø±¹¿¡¼­´Â Àû±ØÀûÀÎ »óȯ Á¤Ã¥ÀÌ ¼±ÁøÀûÀÎ »óó ÄÉ¾î ¹× ¹Ú¸® Á¦Ç°ÀÇ Ã¤¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεé·ÎºÎÅÍ, »óó °³¹ßÀº È¿°úÀûÀÎ »óó °ü¸® Àü·«ÀÇ ÇÙ½ÉÀ̸ç, Çö´ë °Ç°­ °ü¸®ÀÇ ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â Çõ½ÅÀûÀÎ ±â¼úÀÇ ÅëÇÕÀ¸·Î °è¼Ó ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¼ÓÀûÀÎ ÁøÈ­´Â »óó Ä¡·á¿¡¼­ Ä¡·á ¼ºÀû Çâ»ó, Áøº¸ ÀûÀÀ, Ä¡·á È¿À²¼º¿¡ À־ ±«»çÁ¶Á÷ Á¦°Å°¡ ¼öÇàÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶ÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 36°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Wound Debridement Products Market to Reach US$1.7 Billion by 2030

The global market for Wound Debridement Products estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Enzymatic Wound Debridement Products, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$774.1 Million by the end of the analysis period. Growth in the Surgical Wound Debridement Products segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$296.9 Million While China is Forecast to Grow at 9.8% CAGR

The Wound Debridement Products market in the U.S. is estimated at US$296.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$412.7 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Wound Debridement Products Market - Key Trends and Drivers Summarized

Wound debridement is a critical procedure in managing chronic wounds such as pressure ulcers, venous ulcers, and diabetic foot ulcers, essential for promoting the healing process. This medical procedure involves the removal of necrotic or dead tissue, which impedes healing by harboring bacteria and obstructing the growth of new tissue. Various methods of debridement cater to different types of wounds and their specific conditions, making it a versatile and crucial aspect of wound management. Autolytic debridement utilizes the body's own mechanisms to remove non-viable tissue gently, ideal for non-infected wounds. Biological debridement, or larval therapy, and enzymatic debridement offer targeted removal of dead tissue, suitable for larger or infected wounds. Mechanical and sharp debridement provide quicker solutions, with the latter offering immediate improvement and being particularly useful in rapidly assessing and treating underlying conditions.

The market for wound debridement products is expanding due to several growth drivers. The increasing prevalence of chronic wounds necessitates frequent debridements, fostering demand for efficient debridement products. Technological advancements in wound care enhance the effectiveness of treatments, making advanced products more appealing. Furthermore, the aging global population, more prone to chronic conditions needing wound management, significantly contributes to the market's growth. Enhanced awareness and education among healthcare professionals and patients about the benefits of proper wound care, alongside improved healthcare expenditures allowing for better access to quality wound care, are also pivotal growth drivers.

The development and use of wound debridement products are also influenced by favorable regulatory and reimbursement scenarios. Faster and more frequent regulatory approvals for new and innovative products motivate continued investment in research and development. Moreover, positive reimbursement policies, particularly in developed countries, bolster the adoption of advanced wound care and debridement products. These factors collectively ensure that wound debridement remains a cornerstone of effective wound management strategies, continuously evolving with the integration of innovative techniques to meet the needs of modern healthcare. This ongoing evolution underscores the critical role of debridement in enhancing therapeutic outcomes in wound care, adapting to advancements and increasing efficiency in medical treatments.

Select Competitors (Total 36 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â